Ocular Therapeutix, Inc

(NASDAQ:OCUL)

Latest On Ocular Therapeutix, Inc (OCUL):

Date/Time Type Description Signal Details
2023-05-18 23:34 ESTNewsOcular Therapeutix: I Still Don't See The NeedN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix GAAP EPS of -$0.39 misses by $0.12, revenue of $13.37M misses by $0.73MN/A
2023-05-09 02:50 ESTNewsOcular Therapeutix, Inc. (OCUL) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 01:03 ESTNewsOcular Therapeutix Q1 2023 Earnings PreviewN/A
2023-03-07 22:48 ESTNewsOcular Therapeutix stock rises after posting Q4 results beat, strong guidanceN/A
2023-03-07 08:01 ESTNewsOcular Therapeutix, Inc. (OCUL) Q4 2022 Earnings Call TranscriptN/A
2023-03-06 17:33 ESTNewsOcular Therapeutix Q4 GAAP EPS, revenue beats, guidance below consensusN/A
2023-03-06 02:44 ESTNewsOcular Therapeutix Q4 2022 Earnings PreviewN/A
2023-03-04 00:55 ESTNewsOcular Therapeutix: A Promising Turnaround PlayN/A
2023-02-14 11:58 ESTNewsNext Round Of Financing Will Be Transformational For Ocular TherapeutixN/A
2023-02-13 09:49 ESTNewsOcular stock rises ~15% as eye drug implant shows promise in ongoing phase 1 trialN/A
2023-02-12 21:43 ESTNewsOcular Therapeutix: A 'Buy' On Maturing Wet AMD DataN/A
2022-12-12 00:53 ESTNewsOcular Therapeutix: Good Potential, But Not That Good An ExecutionN/A
2022-11-08 16:55 ESTNewsOcular falls 12% as eye therapy Dextenza Q3 sales decline, cuts FY22 outlookN/A
2022-11-08 16:55 ESTNewsOcular Therapeutix hits 52-week low after slashing revenue guidanceN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix GAAP EPS of -$0.31 misses by $0.07, revenue of $11.97M misses by $2.3MN/A
2022-11-07 22:46 ESTNewsOcular Therapeutix, Inc. (OCUL) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 06:22 ESTNewsOcular Therapeutix Q3 2022 Earnings PreviewN/A
2022-09-27 15:05 ESTNewsOcular stock rises as eye drug implant OTX-TKI shows promise in vision disorder in trialN/A
2022-08-22 02:45 ESTNewsOcular Therapeutix: Dextenza Sales Accelerating And Near-Term Catalyst ApproachingN/A
2022-08-15 19:39 ESTNewsOcular Therapeutix: Trading Ahead Of An Underappreciated Catalyst EventN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix GAAP EPS of -$0.25 misses by $0.02, revenue of $12.26M misses by $1.99MN/A
2022-08-09 06:07 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 05:34 ESTNewsOcular Therapeutix Q2 2022 Earnings PreviewN/A
2022-05-10 11:19 ESTNewsOcular Therapeutix GAAP EPS of -$0.22 beats by $0.03, revenue of $13.19M misses by $0.77MN/A
2022-05-10 11:18 ESTNewsOcular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 05:46 ESTNewsOcular Therapeutix Q1 2022 Earnings PreviewN/A
2022-03-29 07:01 ESTNewsOcular Therapeutix: A Follow-UpN/A
2022-03-08 17:48 ESTNewsOcular Therapeutix: Transformative Year Ahead Full Of Important MilestonesN/A
2022-03-01 10:49 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 16:33 ESTNewsOcular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13MN/A
2022-02-27 21:16 ESTNewsOcular Therapeutix Q4 2021 Earnings PreviewN/A
2022-01-19 15:59 ESTNewsOcular Therapeutix owner buys 50,000 shares worth ~$300KN/A
2022-01-19 00:54 ESTNewsAffaMed Therapeutics begins dosing in China trial of DEXTENZA to treat ocular inflammationN/A
2022-01-08 01:34 ESTNewsOcular Therapeutix: Shaken By Covid, Perfectly Positioned For Long-Term GainsN/A
2021-12-12 09:46 ESTNewsHighlighting Ocular TherapeutixN/A
2021-12-10 00:37 ESTNewsOcular Therapeutix trades high on director acquiring 60.9K sharesN/A
2021-12-08 10:52 ESTNewsWarning: OCUL is at high risk of performing badlyN/A
2021-12-06 20:03 ESTNewsOcular Therapeutix reports positive OTX-DED data in mid-stage dry eye disease studyN/A
2021-11-09 14:12 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 16:27 ESTNewsOcular Therapeutix EPS beats by $0.04, misses on revenueN/A
2021-11-07 19:57 ESTNewsOcular Therapeutix Q3 2021 Earnings PreviewN/A
2021-10-24 05:07 ESTNewsMeiraGTx, Aurinia among healthcare gainers this week; Jasper slips after twofold riseN/A
2021-10-22 16:55 ESTNewsOcular Therapeutix posts topline results from mid-stage OTX-CSI dry eye disease trialN/A
2021-10-11 15:36 ESTNewsOcular Therapeutix gains on FDA approval of DEXTENZA for new indicationN/A
2021-10-11 15:36 ESTNewsOyster Point benefits from Ocular sNDA approval; shares up 13%N/A
2021-08-10 09:07 ESTNewsOcular Therapeutix EPS misses by $0.05, beats on revenueN/A
2021-08-10 09:06 ESTNewsOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-09 12:28 ESTNewsOcular Therapeutix: Why I'm Buying The DipN/A
2021-08-06 08:09 ESTNewsOcular Therapeutix and Regeneron scrap collaboration agreementN/A

About Ocular Therapeutix, Inc (OCUL):

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant administered by the fine-gauge needle that is in phase 1 clinical trial for the treatment of wet age-related macular degeneration; OTX-TIC, a travoprost intracameral implant, which is in phase 1 clinical trial for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that is in phase 2 clinical trial for the chronic treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trial for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company is involved in the development of OTX-AFS, an aflibercept suprachoroidal injection for the treatment of retinal diseases. It has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

OCUL Quotes by TradingView

See Advanced Chart

General

  • Name Ocular Therapeutix, Inc
  • Symbol OCUL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 181
  • Fiscal Year EndDecember
  • IPO Date2014-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.ocutx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 91.26
  • Price/Book (Most Recent Quarter) 124.04
  • Enterprise Value Revenue 87.16
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.69
  • Next Year EPS Estimate -$0.25
  • Next Quarter EPS Estimate -$0.17
  • Operating Margin -361%
  • Return on Assets -23%
  • Return on Equity -430%
  • Revenue 17.4 million
  • Earnings Per Share -$1.79
  • Revenue Per Share $0.29
  • Gross Profit -13374000
  • Quarterly Earnings Growth 225.8%
View More

Highlights

  • Market Capitalization 1.55 billion
  • EBITDA -71014000
  • PE Ratio -9.94
  • Analyst Target Price $25.5
  • Book Value Per Share $1.00
View More

Share Statistics

  • Shares Outstanding 76.07 million
  • Shares Float 66.88 million
  • % Held by Insiders 466%
  • % Held by Institutions 55.42%
  • Shares Short 5.07 million
  • Shares Short Prior Month 4.75 million
  • Short Ratio 4.88
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.19
  • 52 Week High $24.3
  • 52 Week Low $4.09
  • 50 Day Moving Average 19.01
  • 200 Day Moving Average 15.53
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ocular Therapeutix, Inc (OCUL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ocular Therapeutix, Inc (OCUL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$7.35 million-$0.23-$0.17-35.82%
2020-09-302020-11-05$5.88 million-$0.19-$0.2522.98%
2020-06-302020-08-07$N/A-$0.64-$0.32-97.96%
2020-03-312020-05-08$2.61 million-$0.41-$0.5017.17%
2019-12-312020-03-12$2.26 million-$0.53-$0.42-26.19%
2019-09-302019-11-12$829000-$0.45-$0.462.17%
2019-06-302019-08-07$650000-$0.57-$0.48-17.94%
2019-03-312019-05-10$492000-$0.41-$0.421.2%
2018-12-312019-03-07$504000-$0.42-$0.38-9.38%
2018-09-302018-11-07$498000-$0.38-$0.37-2.7%
2018-06-302018-08-07$648000-$0.37-$0.381.33%
2018-03-312018-05-08$340000-$0.40-$0.412.44%
2017-12-312018-03-08$487000-$0.44-$0.5316.98%
2017-09-302017-11-07$523000-$0.54-$0.53-1.89%
2017-06-302017-08-08$438000-$0.64-$0.57-11.5%
2017-03-312017-05-05$475000-$0.58-$0.48-20.01%
2016-12-312017-03-10$511000-$0.52-$0.46-13.66%
2016-09-302016-11-09$477000-$0.39-$0.5021.61%
2016-06-302016-08-09$441000-$0.46-$0.495.49%
2016-03-312016-05-10$458000-$0.44-$0.43-1.95%
2015-12-312016-03-10$436000-$0.43-$0.479.15%
2015-09-302015-11-10$429000-$0.47-$0.38-23.68%
2015-06-302015-08-10$459000-$0.45-$0.33-36.36%
2015-03-312015-05-15$426000-$0.35-$0.3910.26%
2014-12-312015-03-10$505000-$0.37-$0.382.63%
2014-09-302014-11-12$143000-$0.48-$0.43-11.63%
2014-06-302014-08-29$97000-$2.10

Ocular Therapeutix, Inc (OCUL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ocular Therapeutix, Inc (OCUL) Chart:

Ocular Therapeutix, Inc (OCUL) News:

Below you will find a list of latest news for Ocular Therapeutix, Inc (OCUL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ocular Therapeutix, Inc (OCUL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-192.50CALL0 0799.82TRUE00
2025-09-1953.98CALL0 38473.79TRUE00
2025-09-197.55.8CALL0 10780TRUE00
2025-09-19102.89CALL3 3119132.2TRUE-0.06-0.02
2025-09-1912.50.75CALL2 538280.3TRUE-0.15-0.17
2025-09-19150.14CALL14 407998.73FALSE-0.06-0.3
2025-09-1917.50.35CALL0 35223.63FALSE00
2025-09-192.50PUT0 01188.58FALSE00
2025-09-1950PUT0 23342.97FALSE00
2025-09-197.50.12PUT0 81239.63FALSE00
2025-09-19100.3PUT0 2169224.8FALSE00
2025-09-1912.50.8PUT0 51270.88FALSE00
2025-09-19152.05PUT0 276.21TRUE00
2025-09-1917.54.8PUT0 280TRUE00
2025-10-172.50CALL0 0452TRUE00
2025-10-1750CALL0 0339.76TRUE00
2025-10-177.50CALL0 0193.57TRUE00
2025-10-17103.1CALL1 152985.52TRUE0.10.03
2025-10-1712.51.45CALL542 207575TRUE0.150.12
2025-10-17150.53CALL10 110677.84FALSE-0.07-0.12
2025-10-1717.50.24CALL0 5191.23FALSE00
2025-10-17200.1CALL0 1125.2FALSE00
2025-10-1722.50CALL0 0164.46FALSE00
2025-10-17250CALL0 0177.88FALSE00
2025-10-172.50PUT0 0496.42FALSE00
2025-10-1750PUT0 0293.58FALSE00
2025-10-177.50PUT0 0187.24FALSE00
2025-10-17100.2PUT0 2678.22FALSE00
2025-10-1712.51.01PUT3 7973.64FALSE0.060.06
2025-10-17153.23PUT0 373.63TRUE00
2025-10-1717.50PUT0 069.84TRUE00
2025-10-17200PUT0 0123.28TRUE00
2025-10-1722.50PUT0 00TRUE00
2025-10-17250PUT0 00TRUE00
2025-12-192.50CALL0 0235.22TRUE00
2025-12-1956.76CALL0 40163.43TRUE00
2025-12-197.55.9CALL0 21113.83TRUE00
2025-12-19102.95CALL0 69369.49TRUE00
2025-12-1912.52CALL1 14668.89TRUE20
2025-12-19151CALL0 85165.02FALSE00
2025-12-1917.50.7CALL0 25276.46FALSE00
2025-12-19200CALL0 077.6FALSE00
2025-12-1922.50.18CALL0 576.79FALSE00
2025-12-19250CALL0 0122.31FALSE00
2025-12-192.50PUT0 0339.96FALSE00
2025-12-1950PUT0 23199.8FALSE00
2025-12-197.50.14PUT0 46192.66FALSE00
2025-12-19100.75PUT0 64169.61FALSE00
2025-12-1912.51.69PUT0 12568.78FALSE00
2025-12-19154.3PUT0 366.39TRUE00
2025-12-1917.50PUT0 070.38TRUE00
2025-12-19200PUT0 0101.29TRUE00
2025-12-1922.50PUT0 081.64TRUE00
2025-12-19250PUT0 0109.44TRUE00
2026-01-162.50CALL0 18227.6TRUE00
2026-01-1636.3CALL0 550TRUE00
2026-01-163.57.5CALL0 54194.21TRUE00
2026-01-1648.5CALL0 57167.89TRUE00
2026-01-164.55CALL0 28130.9TRUE00
2026-01-1658.2CALL4 11289.93TRUE8.20
2026-01-165.58.1CALL0 7991.02TRUE00
2026-01-1676.13CALL1 209986.64TRUE6.130
2026-01-16103.84CALL0 646776.92TRUE00
2026-01-1612.52.42CALL0 640773.2TRUE00
2026-01-16151.5CALL0 379974.76FALSE00
2026-01-1617.51.25CALL0 4372.88FALSE00
2026-01-16200.55CALL0 422381.59FALSE00
2026-01-1622.50.45CALL0 4784.24FALSE00
2026-01-16250CALL0 091.25FALSE00
2026-01-162.50PUT0 7633.49FALSE00
2026-01-1630PUT0 0264.84FALSE00
2026-01-163.50PUT0 0236.67FALSE00
2026-01-1640PUT0 25177.84FALSE00
2026-01-164.50PUT0 3223.48FALSE00
2026-01-1650.1PUT0 35130.08FALSE00
2026-01-165.50.13PUT0 32174.34FALSE00
2026-01-1670.22PUT0 26182.92FALSE00
2026-01-16100.85PUT1 97874.89FALSE0.850
2026-01-1612.52.01PUT0 59772.58FALSE00
2026-01-16153.9PUT0 1270.6TRUE00
2026-01-1617.50PUT0 6075.24TRUE00
2026-01-16200PUT0 062.7TRUE00
2026-01-1622.50PUT0 097.31TRUE00
2026-01-16250PUT0 090.32TRUE00
2026-03-202.50CALL0 0192.59TRUE00
2026-03-2050CALL0 0151.67TRUE00
2026-03-207.50CALL0 0125.68TRUE00
2026-03-20104.8CALL0 8104.83TRUE00
2026-03-2012.53.9CALL17 173103.32TRUE3.90
2026-03-20153.4CALL0 196102.81FALSE00
2026-03-2017.52.25CALL0 122100.61FALSE00
2026-03-20202.5CALL0 10795.01FALSE00
2026-03-2022.51.15CALL0 9593.72FALSE00
2026-03-20250CALL0 093.58FALSE00
2026-03-202.50PUT0 0282.24FALSE00
2026-03-2050PUT0 0170.95FALSE00
2026-03-207.50.9PUT0 1130.92FALSE00
2026-03-20102.23PUT0 2104.97FALSE00
2026-03-2012.53.3PUT81 307100.12FALSE-0.1-0.03
2026-03-20154.8PUT0 237102.83TRUE00
2026-03-2017.50PUT0 093.18TRUE00
2026-03-20200PUT0 088.47TRUE00
2026-03-2022.50PUT0 088.64TRUE00
2026-03-20250PUT0 087.19TRUE00
2026-04-172.50CALL0 0220.96TRUE00
2026-04-1757.5CALL0 12126.49TRUE00
2026-04-177.56.9CALL0 38107.74TRUE00
2026-04-17105.19CALL50 1191103.71TRUE5.190
2026-04-1712.54CALL0 2125103.08TRUE00
2026-04-17153.4CALL0 11095.02FALSE00
2026-04-1717.52.25CALL0 11391.73FALSE00
2026-04-17202CALL0 8890.42FALSE00
2026-04-1722.51.05CALL4 46588.68FALSE1.050
2026-04-17250CALL0 089.44FALSE00
2026-04-172.50.2PUT0 1270.77FALSE00
2026-04-1750PUT0 0169.95FALSE00
2026-04-177.51.13PUT0 1080111.45FALSE00
2026-04-17102.15PUT9 1870101.72FALSE-0.03-0.01
2026-04-1712.53.74PUT0 2100.93FALSE00
2026-04-17154.6PUT0 396.61TRUE00
2026-04-1717.56.17PUT0 695.4TRUE00
2026-04-17200PUT0 088.91TRUE00
2026-04-1722.50PUT0 086.78TRUE00
2026-04-17250PUT0 080.8TRUE00

Latest OCUL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST18$3.565
Jun 13, 2022 7:59 PM EST100$3.57
Jun 13, 2022 7:59 PM EST5$3.565
Jun 13, 2022 7:59 PM EST2$3.565

Ocular Therapeutix, Inc (OCUL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2019-02-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019001625/0000000000-19-001625-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1393434/000000000019006740/0000000000-19-006740-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000005341719000053/0000053417-19-000053-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000021545719006851/0000215457-19-006851-index.htm
2018-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506618002543/0000315066-18-002543-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000031506619001221/0000315066-19-001221-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720006050/0000834237-20-006050-index.htm
2020-06-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000083423720009555/0000834237-20-009555-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000008/0000893838-19-000008-index.htm
2019-03-04SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000010/0000893838-19-000010-index.htm
2019-04-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000089383819000011/0000893838-19-000011-index.htm
2019-05-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514819000611/0000905148-19-000611-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000090514820000304/0000905148-20-000304-index.htm
2018-12-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746918007791/0001047469-18-007791-index.htm
2019-04-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1393434/000104746919001837/0001047469-19-001837-index.htm
2019-04-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002010/0001047469-19-002010-index.htm
2019-04-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1393434/000104746919002765/0001047469-19-002765-index.htm
2020-05-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003131/0001047469-20-003131-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000104746920003152/0001047469-20-003152-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918066652/0001104659-18-066652-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465918075138/0001104659-18-075138-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000887/0001104659-19-000887-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000889/0001104659-19-000889-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000890/0001104659-19-000890-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000891/0001104659-19-000891-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000892/0001104659-19-000892-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919000894/0001104659-19-000894-index.htm
2019-01-16DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919002007/0001104659-19-002007-index.htm
2019-02-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919006823/0001104659-19-006823-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009429/0001104659-19-009429-index.htm
2019-02-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919009989/0001104659-19-009989-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013380/0001104659-19-013380-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919013389/0001104659-19-013389-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-03-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016897/0001104659-19-016897-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016898/0001104659-19-016898-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919016981/0001104659-19-016981-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919020175/0001104659-19-020175-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023120/0001104659-19-023120-index.htm
2019-04-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1393434/000110465919023739/0001104659-19-023739-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919024896/0001104659-19-024896-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919028431/0001104659-19-028431-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919029753/0001104659-19-029753-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919030555/0001104659-19-030555-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032737/0001104659-19-032737-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919033292/0001104659-19-033292-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034285/0001104659-19-034285-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-06-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035409/0001104659-19-035409-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035410/0001104659-19-035410-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035411/0001104659-19-035411-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035412/0001104659-19-035412-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035413/0001104659-19-035413-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035414/0001104659-19-035414-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919035515/0001104659-19-035515-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919036832/0001104659-19-036832-index.htm
2019-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039304/0001104659-19-039304-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465919039308/0001104659-19-039308-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919044532/0001104659-19-044532-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919051114/0001104659-19-051114-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919061710/0001104659-19-061710-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465919062030/0001104659-19-062030-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009939/0001104659-20-009939-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009941/0001104659-20-009941-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009943/0001104659-20-009943-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920009945/0001104659-20-009945-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920012235/0001104659-20-012235-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920021085/0001104659-20-021085-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920028268/0001104659-20-028268-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032464/0001104659-20-032464-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920032495/0001104659-20-032495-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920045708/0001104659-20-045708-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920051935/0001104659-20-051935-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920058381/0001104659-20-058381-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920061664/0001104659-20-061664-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920065123/0001104659-20-065123-index.htm
2020-06-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000110465920073398/0001104659-20-073398-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077440/0001104659-20-077440-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077441/0001104659-20-077441-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077444/0001104659-20-077444-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077446/0001104659-20-077446-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077448/0001104659-20-077448-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920077449/0001104659-20-077449-index.htm
2020-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920079714/0001104659-20-079714-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920080918/0001104659-20-080918-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920083953/0001104659-20-083953-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920084290/0001104659-20-084290-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920091724/0001104659-20-091724-index.htm
2020-09-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920108898/0001104659-20-108898-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112646/0001104659-20-112646-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920112885/0001104659-20-112885-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920114553/0001104659-20-114553-index.htm
2020-10-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114581/0001104659-20-114581-index.htm
2020-10-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1393434/000110465920114906/0001104659-20-114906-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920115475/0001104659-20-115475-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920119750/0001104659-20-119750-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000110465920121801/0001104659-20-121801-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000113777419000037/0001137774-19-000037-index.htm
2020-03-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120006856/0001140361-20-006856-index.htm
2020-05-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1393434/000114036120012177/0001140361-20-012177-index.htm
2019-03-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000139343419000001/0001393434-19-000001-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1393434/000141057818000569/0001410578-18-000569-index.htm
2019-05-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219006391/0001493152-19-006391-index.htm
2019-12-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315219019793/0001493152-19-019793-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220000453/0001493152-20-000453-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000149315220005795/0001493152-20-005795-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837018008793/0001558370-18-008793-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837019001659/0001558370-19-001659-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003296/0001558370-19-003296-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837019003299/0001558370-19-003299-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019004776/0001558370-19-004776-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019007462/0001558370-19-007462-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837019010684/0001558370-19-010684-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1393434/000155837020002537/0001558370-20-002537-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004640/0001558370-20-004640-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1393434/000155837020004644/0001558370-20-004644-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020005871/0001558370-20-005871-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020009817/0001558370-20-009817-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1393434/000155837020012870/0001558370-20-012870-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761919006040/0001567619-19-006040-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-02-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000194/9999999995-19-000194-index.htm
2019-04-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1393434/999999999519000902/9999999995-19-000902-index.htm
2019-10-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1393434/999999999719007342/9999999997-19-007342-index.htm

Ocular Therapeutix, Inc (OCUL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ocular Therapeutix, Inc (OCUL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 466%
Institutional Ownership: 5542%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-10Kevin F. HanleyOfficerBuy10,000.005.6056,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072563/0001104659-18-072563-index.htm
2019-03-13RICHARD L MD LINDSTROMDirectorBuy56,441.004.33244,389.53100,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919014844/0001104659-19-014844-index.htm
2019-06-07Amarpreet SawhneyChairman of the BoardBuy65,468.003.02197,713.361,056,031.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm
2019-03-15Michael H. GoldsteinChief Medical OfficerBuy10,000.004.1541,500.0013,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015691/0001104659-19-015691-index.htm
2018-12-14Kevin F. HanleyOfficerBuy10,000.005.5055,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918073444/0001104659-18-073444-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy5,000.003.9719,852.50207,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2019-03-15Jeffrey S. HeierDirectorBuy24,000.004.1599,600.0024,000.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919015692/0001104659-19-015692-index.htm
2019-06-14Donald NotmanChief Financial OfficerBuy2,500.004.3310,825.0024,049.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036009/0001104659-19-036009-index.htm
2019-05-28Michael H. GoldsteinChief Medical OfficerBuy12,000.002.5130,120.0025,686.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919032741/0001104659-19-032741-index.htm
2020-03-13SUMMER ROAD LLC10% Share HolderBuy210,800.004.63975,982.924,015,588.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2020-03-16SUMMER ROAD LLC10% Share HolderBuy194,262.004.16807,216.894,209,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2018-12-06Daniel M BollagOfficerBuy17,400.005.76100,224.0042,100.00https://www.sec.gov/Archives/edgar/data/1393434/000110465918072100/0001104659-18-072100-index.htm
2019-06-14Leslie J. WilliamsDirectorBuy4,500.004.4019,800.004,500.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919036008/0001104659-19-036008-index.htm
2020-03-17SUMMER ROAD LLC10% Share HolderBuy550,000.004.662,562,890.004,759,850.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006639/0001567619-20-006639-index.htm
2019-12-30Opaleye Management Inc.10% Share HolderBuy15,000.003.9759,557.504,903,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000059/0001493152-20-000059-index.htm
2020-01-02Opaleye Management Inc.10% Share HolderBuy15,000.003.9058,507.504,918,500.00https://www.sec.gov/Archives/edgar/data/1393434/000149315220000167/0001493152-20-000167-index.htm
2020-03-18SUMMER ROAD LLC10% Share HolderBuy344,938.004.621,594,199.955,104,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-19SUMMER ROAD LLC10% Share HolderBuy40,900.004.63189,223.855,145,688.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006870/0001567619-20-006870-index.htm
2020-03-20SUMMER ROAD LLC10% Share HolderBuy9,100.004.5241,119.265,154,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-23SUMMER ROAD LLC10% Share HolderBuy64,948.004.66302,365.415,219,736.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-03-24SUMMER ROAD LLC10% Share HolderBuy35,052.004.87170,713.765,254,788.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920006975/0001567619-20-006975-index.htm
2020-05-19SUMMER ROAD LLC10% Share HolderBuy363,636.005.501,999,998.005,618,424.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920010898/0001567619-20-010898-index.htm
2020-10-16SUMMER ROAD LLC10% Share HolderBuy437.0010.484,579.765,618,861.00https://www.sec.gov/Archives/edgar/data/1393434/000156761920017996/0001567619-20-017996-index.htm
2019-06-04Amarpreet SawhneyChairman of the BoardBuy12,928.002.9237,749.76898,711.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-05Amarpreet SawhneyChairman of the BoardBuy32,852.002.9195,599.32931,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/0001104659-19-034353-index.htm
2019-06-06Antony C. MattessichPresident & CEOBuy40,000.002.81112,400.0097,900.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034632/0001104659-19-034632-index.htm
2019-06-06Amarpreet SawhneyChairman of the BoardBuy59,000.002.80165,200.00990,563.00https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/0001104659-19-034633-index.htm